2nd Int’l Congress on Clinical Trials in Oncology & Hemato-Oncology 2018

Start Date : February 19, 2018
End Date : February 20, 2018
Time : 7:00 am to5:00 pm

Phone : +44 203514032
Email : icto@bioevents.net

Location :
Hilton Berlin, Mohrenstrasse 30, Berlin, 10117, Germany



It gives us great pleasure to invite you to attend The 2nd International Congress on Clinical Trials in Oncology and Hemato-Oncology (ICTO2018) scheduled to take place in Berlin, Germany from 19-20 February 2018.


ICTO2018 follows the success of the 1st inaugural Congress which took place March 2017 in London and will again bring together world renowned speakers in the field of Clinical Trials in Oncology and Hemato-Oncology.  The Congress will welcome oncology professionals, treatment experts, CRO’s, industry leaders and other experts to the majestic city of Berlin.


ICTO2018 will provide an outstanding scientific, educational and networking experience.


The congress will focus on areas including:


- Design of clinical trials in the new era - Personalized cancer medicine

- Immuno-oncology

- Monitoring of Trials and Statistics

- Regulations – Survival based Medicine

- Phase 4 Trials

- Expanded access trials

- Ethics and Patients’ Rights

- Healthcare economy


Our goal is for ICTO2018 to be the forerunner in analysis, interpretation and translation of data and knowledge relating to Clinical Trials in Oncology and Hemato-Oncology.


We look forward to welcoming you as part of this exciting and dynamic Congress.


For sponsorship and Exhibition opportunities contact icto@bioevents.net


Special Offers for Start-Up companies available. contact icto@bioevents.net for more information.


Industry starts from : USD 1000

Physician/Practicing  Medical Professional/ Academic starts from: USD 600

Developing Countries starting from : USD 499

Speakers: talia golan, raanan berger, Robin Foà, Michele Milella, Jens Siveke

Registration Info

Register Now


Organized by

Organized by LoveEvvnt1


Event Categories: Oncology.

Your Review

You must be logged in to post a comment.